serous

Low grade serous ovarian carcinoma: identifying variations in practice patterns
John Siemon, David M Gershenson, Brian Slomovitz, Matthew Schlumbrecht

International Journal of Gynecologic Cancer Jan 2019, 29 (1) 174-180; DOI: 10.1136/ijgc-2018-000018
There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
Richard Schwameis, Luis Chiva, Philipp Harter

International Journal of Gynecologic Cancer Apr 2022, 32 (4) 578; DOI: 10.1136/ijgc-2022-003348
Management of low-grade serous ovarian neoplasm in the setting of fertility preservation
Zibi Marchocki, Marjan Rouzbahman, Tanya Chawla, Taymaa May

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1834-1839; DOI: 10.1136/ijgc-2020-001838
Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer
Mustafa Zelal Muallem, Jalid Sehouli, Rolf Richter, Aygun Babayeva, Khayal Gasimli, Asya Parashkevova

International Journal of Gynecologic Cancer Jan 2020, 30 (1) 62-66; DOI: 10.1136/ijgc-2019-000778
Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas
Cassandra B Dowson, Colin Stewart, Sarah O'Sullivan, Nicholas Pachter, Lyn Schofield, Paul A Cohen

International Journal of Gynecologic Cancer Jan 2020, 30 (1) 94-99; DOI: 10.1136/ijgc-2019-000540
Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology—A Comparative Study
Tine H. Schnack, Estrid Høgdall, Lotte Nedergaard, Claus Høgdall

International Journal of Gynecologic Cancer Jan 2016, 26 (1) 82-90; DOI: 10.1097/IGC.0000000000000585
ATL
Shazia Bashir, Gaofeng Jiang, Ayesha Joshi, Christopher Miller, Cathleen Matrai, Anna Yemelyanova, Thomas A. Caputo, Kevin M. Holcomb, Lora Hedrick Ellenson, Divya Gupta

International Journal of Gynecologic Cancer Sep 2014, 24 (7) 1262-1267; DOI: 10.1097/IGC.0000000000000183
The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study
Ingrid Vandenput, Jone Trovik, Ignace Vergote, Philippe Moerman, Karin Leunen, Patrick Berteloot, Patrick Neven, Helga Salvesen, Frédéric Amant

International Journal of Gynecologic Cancer Jan 2011, 21 (2) 332-336; DOI: 10.1097/IGC.0b013e3182094ded
A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome
D. Faratian, A. Stillie, R. M.C. Busby-Earle, V. J. Cowie, H. Monaghan

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 972-978; DOI: 10.1136/ijgc-00009577-200605000-00003
Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
E. Despierre, P. Moerman, I. Vergote, F. Amant

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 273-277; DOI: 10.1136/ijgc-00009577-200602001-00044

Main menu

serous

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

serous

Pages